Color coded perfusion imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following trans-arterial chemoembolization (TACE) of hepatocellular carcinoma.

Color coded perfusion imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following trans-arterial chemoembolization (TACE) of hepatocellular carcinoma.

<h4>Aim</h4>Evaluation of an external color coded perfusion quantification software with CEUS for the post-interventional success control following TACE in patients with HCC.<h4>Material and methods</h4>31 patients (5 females, 26 males, age range 34-82 years, mean 66.8 years)...

Full description

Bibliographic Details
Main Authors:	Janine Rennert, Isabel Wiesinger, Andreas Schicho, Lukas Philip Beyer, Philipp Wiggermann, Christian Stroszczynski, Ernst Michael Jung
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2019-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0217599

Similar Items

Quantification of dynamic contrast-enhanced ultrasound (CEUS) in non-cystic breast lesions using external perfusion software
by: Ernst Michael Jung, et al.
Published: (2021-09-01)

Continuous Dynamic Registration of Microvascularization of Liver Tumors with Contrast-Enhanced Ultrasound
by: Lukas Philipp Beyer, et al.
Published: (2014-01-01)

Is Strain Elastography (IO-SE) Sufficient for Characterization of Liver Lesions before Surgical Resection--Or Is Contrast Enhanced Ultrasound (CEUS) Necessary?
by: Ernst Michael Jung, et al.
Published: (2015-01-01)

Detection of Incomplete Irreversible Electroporation (IRE) and Microwave Ablation (MWA) of Hepatocellular Carcinoma (HCC) Using Iodine Quantification in Dual Energy Computed Tomography (DECT)
by: Wolf Bäumler, et al.
Published: (2022-04-01)

Emphysematous cystitis: mortality, risk factors, and pathogens of a rare disease
by: Andreas Schicho, et al.
Published: (2017-04-01)

Long-term survival after percutaneous irreversible electroporation of inoperable colorectal liver metastases
by: Schicho A, et al.
Published: (2018-12-01)

Predictive factors of trans-arterial chemoembolization (tace) efficacy for hepatocellular carcinoma in arterial phase computed tomographic scan
by: Mohamed , Dahlia
Published: (2017)

Efficacy of Transarterial Chemoembolization (TACE) for Early-Stage Hepatocellular Carcinoma
by: Moonhyung Lee, et al.
Published: (2023-12-01)

Trans-arterial chemoembolization (TACE) in patients with unresectable Hepatocellular carcinoma: Experience from a tertiary care centre in India
by: Shashi Bala Paul, et al.
Published: (2011-04-01)

Systematic Review and Meta-analysis of Endostar Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone for Hepatocellular Carcinoma
by: Ya-Qing Zhang MM, et al.
Published: (2017-10-01)

Transarterial chemoembolization (TACE) plus sorafenib versus TACE for intermediate or advanced stage hepatocellular carcinoma: a meta-analysis.
by: Leida Zhang, et al.
Published: (2014-01-01)

Stereotactically-navigated percutaneous Irreversible Electroporation (IRE) compared to conventional IRE: a prospective trial
by: Lukas P. Beyer, et al.
Published: (2016-08-01)

A review of applying transarterial chemoembolization (TACE) method for management of hepatocellular carcinoma
by: Hossein Ghanaati, et al.
Published: (2021-01-01)

Feasibility of contrast-enhanced ultrasonography (CEUS) in evaluating renal microvascular perfusion in pediatric patients
by: Wei Zhang, et al.
Published: (2022-11-01)

Is contrast-enhanced ultrasonography (CEUS) useful in the assessment of obstructive uropathy-induced perfusion disorders?
by: Ustyniak Sergiusz, et al.
Published: (2021-11-01)

Subtraction MRI versus diffusion weighted imaging: Which is more accurate in assessment of hepatocellular carcinoma after Trans Arterial Chemoembolization (TACE)?
by: Noha Abd ElShafy ElSaid, et al.
Published: (2016-12-01)

Parametric Imaging of Contrast-Enhanced Ultrasound (CEUS) for the Evaluation of Acute Gastrointestinal Graft-Versus-Host Disease
by: Antonia-Maria Pausch, et al.
Published: (2021-05-01)

Transarterial chemoembolization (TACE) plus tyrosine kinase inhibitors versus TACE in patients with hepatocellular carcinoma: a systematic review and meta-analysis
by: Ruihua Duan, et al.
Published: (2023-03-01)

Outcome of conventional transarterial chemoembolization (cTACE) in the management of spontaneously ruptured hepatocellular carcinoma
by: Yashwant Patidar, et al.
Published: (2019-04-01)

Identification of two distinct hereditary hemorrhagic telangiectasia patient subsets with different hepatic perfusion properties by combination of contrast-enhanced ultrasound (CEUS) with perfusion imaging quantification.
by: Roland C Schelker, et al.
Published: (2019-01-01)

Initial Transarterial Chemoembolization (TACE) Using HepaSpheres 20–40 µm and Subsequent Lipiodol TACE in Patients with Hepatocellular Carcinoma > 5 cm
by: Su Min Cho, et al.
Published: (2021-04-01)

Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): a randomized controlled trial
by: Liang-Cheng Chen, et al.
Published: (2019-03-01)

Chemoembolization with drug-eluting microspheres (DEM-TACE) for hepatocellular carcinoma: single-center review of safety and efficacy
by: Bishay VL, et al.
Published: (2014-11-01)

How to perform Contrast-Enhanced Ultrasound (CEUS)
by: Christoph F. Dietrich, et al.
Published: (2018-01-01)

P-43 INDICATORS OF RESPONSE TO FIRST TRANSARTERIAL CHEMOEMBOLIZATION (TACE) IN HEPATOCELULLAR CARCINOMA
by: Alejandra Domínguez, et al.
Published: (2021-09-01)

No lipiodol, no beads—another transcatheter arterial chemoembolization (TACE) with fine cisplatin powder and porous gelatin particles for TACE‐naïve, multifocal, up‐to‐seven out hepatocellular carcinoma
by: Rui Sato, et al.
Published: (2024-07-01)

Evaluation of patients undergoing Transarterial Chemoembolization (TACE) for Hepatocellular Carcinoma with respect to tumor size, site and number of lesions
by: Amjad Sattar, et al.
Published: (2013-12-01)

Transarterial chemoembolization (TACE) using mitomycin and lipiodol with or without degradable starch microspheres for hepatocellular carcinoma: comparative study
by: Tatjana Gruber-Rouh, et al.
Published: (2018-02-01)

The Value of Contrast-Enhanced Ultrasound (CEUS) in the Detection of Perfusion Disturbances in Abdominal Wall Hernias Compared with Surgical and Histological Assessment
by: Ehsan Safai Zadeh, et al.
Published: (2022-02-01)

Contrast‐enhanced ultrasound (CEUS) of benign and malignant renal tumors: Distinguishing CEUS features differ with tumor size
by: Jianing Zhu, et al.
Published: (2023-02-01)

Utility of contrast enhanced ultrasound (CEUS) in penile trauma
by: Miguel A. Gómez-Bermejo, et al.
Published: (2023-09-01)

Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis
by: Marmorale Cristina, et al.
Published: (2010-12-01)

Prognostic factors for overall survival and safety of trans-arterial chemoembolization (TACE) with irinotecan-loaded drug-eluting beads (DEBIRI) in patients with colorectal liver metastases
by: Sljivic Maja, et al.
Published: (2024-03-01)

Perfusion Patterns of Peripheral Organizing Pneumonia (POP) Using Contrast-Enhanced Ultrasound (CEUS) and Their Correlation with Immunohistochemically Detected Vascularization Patterns
by: Ehsan Safai Zadeh, et al.
Published: (2021-09-01)

Single medium-sized hepatocellular carcinoma treated with sequential conventional transarterial chemoembolization (cTACE) and microwave ablation at 4 weeks versus cTACE alone: a propensity score
by: Zi-yi Zhu, et al.
Published: (2022-06-01)

TACE versus TACE + entecavir versus TACE + tenofovir in the treatment of HBV associated hepatocellular carcinoma
by: Haohao Lu, et al.
Published: (2023-03-01)

CEUS
by: F. J. Ten Cate
Published: (2015-01-01)

Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience
by: Marco Dollinger, et al.
Published: (2015-11-01)

Recent Advances on Polymeric Beads or Hydrogels as Embolization Agents for Improved Transcatheter Arterial Chemoembolization (TACE)
by: Yun-Ping Chen, et al.
Published: (2019-06-01)

Contrast-enhanced ultrasound (CEUS) in the evaluation of bladder pathologies: Review
by: Saubhagya Srivastava, et al.
Published: (2023-12-01)